HEADER HYDROLASE/HYDROLASE INHIBITOR 15-APR-11 3RJM TITLE CASPASE2 IN COMPLEX WITH CHDI LIGAND 33C COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-2; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: RESIDUES 167-333; COMPND 5 SYNONYM: CASP-2, NEURAL PRECURSOR CELL EXPRESSED DEVELOPMENTALLY COMPND 6 DOWN-REGULATED PROTEIN 2, NEDD-2, PROTEASE ICH-1, CASPASE-2 SUBUNIT COMPND 7 P18, CASPASE-2 SUBUNIT P13, CASPASE-2 SUBUNIT P12; COMPND 8 EC: 3.4.22.55; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: CASPASE-2; COMPND 12 CHAIN: B, D; COMPND 13 FRAGMENT: RESIDUES 348-452; COMPND 14 SYNONYM: CASP-2, NEURAL PRECURSOR CELL EXPRESSED DEVELOPMENTALLY COMPND 15 DOWN-REGULATED PROTEIN 2, NEDD-2, PROTEASE ICH-1, CASPASE-2 SUBUNIT COMPND 16 P18, CASPASE-2 SUBUNIT P13, CASPASE-2 SUBUNIT P12; COMPND 17 EC: 3.4.22.55; COMPND 18 ENGINEERED: YES; COMPND 19 MOL_ID: 3; COMPND 20 MOLECULE: PEPTIDE INHIBITOR (ACE)VDV(3PX)D-CHO; COMPND 21 CHAIN: E, F; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP2, CASPASE-2, ICH1, NEDD2, P19; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: CASP2, CASPASE-2, ICH1, NEDD2, P12; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 MOL_ID: 3; SOURCE 18 SYNTHETIC: YES KEYWDS CASPASE-2, P12, P19, CASPASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.ABENDROTH,D.LORIMER,L.STEWART,M.MAILLARD,A.S.KISELYOV REVDAT 4 06-DEC-23 3RJM 1 REMARK REVDAT 3 13-SEP-23 3RJM 1 SEQADV LINK REVDAT 2 05-OCT-11 3RJM 1 JRNL REVDAT 1 21-SEP-11 3RJM 0 JRNL AUTH M.C.MAILLARD,F.A.BROOKFIELD,S.M.COURTNEY,F.M.EUSTACHE, JRNL AUTH 2 M.J.GEMKOW,R.K.HANDEL,L.C.JOHNSON,P.D.JOHNSON,M.A.KERRY, JRNL AUTH 3 F.KRIEGER,M.MENICONI,I.MUNOZ-SANJUAN,J.J.PALFREY,H.PARK, JRNL AUTH 4 S.SCHAERTL,M.G.TAYLOR,D.WEDDELL,C.DOMINGUEZ JRNL TITL EXPLOITING DIFFERENCES IN CASPASE-2 AND -3 S(2) SUBSITES FOR JRNL TITL 2 SELECTIVITY: STRUCTURE-BASED DESIGN, SOLID-PHASE SYNTHESIS JRNL TITL 3 AND IN VITRO ACTIVITY OF NOVEL SUBSTRATE-BASED CASPASE-2 JRNL TITL 4 INHIBITORS. JRNL REF BIOORG.MED.CHEM. V. 19 5833 2011 JRNL REFN ISSN 0968-0896 JRNL PMID 21903398 JRNL DOI 10.1016/J.BMC.2011.08.020 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 20375 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1040 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.62 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1379 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.73 REMARK 3 BIN R VALUE (WORKING SET) : 0.2150 REMARK 3 BIN FREE R VALUE SET COUNT : 81 REMARK 3 BIN FREE R VALUE : 0.3530 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4077 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.72 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 10.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.20000 REMARK 3 B22 (A**2) : 0.03000 REMARK 3 B33 (A**2) : -0.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.306 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.204 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.192 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.879 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4183 ; 0.012 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2806 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5669 ; 1.311 ; 1.961 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6820 ; 0.851 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 521 ; 6.224 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 198 ;34.685 ;23.586 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 681 ;14.390 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;16.785 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 626 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4690 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 870 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2613 ; 0.580 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1057 ; 0.107 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4181 ; 1.135 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1568 ; 1.590 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1480 ; 2.648 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A C REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 2 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 9 A 157 4 REMARK 3 1 C 9 C 157 4 REMARK 3 2 A 402 A 406 4 REMARK 3 2 C 402 C 406 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1980 ; 0.310 ; 0.500 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1980 ; 0.520 ; 2.000 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : B D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 B 207 B 303 4 REMARK 3 1 D 207 D 303 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 2 B (A): 1273 ; 0.270 ; 0.500 REMARK 3 MEDIUM THERMAL 2 B (A**2): 1273 ; 0.530 ; 2.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 4 REMARK 4 3RJM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-APR-11. REMARK 100 THE DEPOSITION ID IS D_1000065012. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-10 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : RIGAKU VARIMAX HF REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20535 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.15700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.4700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.62 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 0.51900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1PYO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26% PEG 3500, 100MM MES PH 6.5 - PH REMARK 280 7.0, SITTING DROP, VAPOR DIFFUSION, TEMPERATURE 290K, VAPOR REMARK 280 DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.88500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.99000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.69000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.99000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.88500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.69000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 17850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -89.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE PEPTIDE INHIBITOR (ACE)VDV(3PX)D-CHO IS PEPTIDE-LIKE, A MEMBER REMARK 400 OF CASPASE INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: PEPTIDE INHIBITOR (ACE)VDV(3PX)D-CHO REMARK 400 CHAIN: E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 ALA A 1 REMARK 465 ASN A 2 REMARK 465 LYS A 3 REMARK 465 ASP A 4 REMARK 465 GLY A 5 REMARK 465 PRO A 6 REMARK 465 VAL A 7 REMARK 465 CYS A 8 REMARK 465 ASP A 168 REMARK 465 MET B 200 REMARK 465 ALA B 201 REMARK 465 GLY B 202 REMARK 465 LYS B 203 REMARK 465 GLU B 204 REMARK 465 LYS B 205 REMARK 465 LEU B 206 REMARK 465 PRO B 304 REMARK 465 THR B 305 REMARK 465 ALA B 306 REMARK 465 ALA B 307 REMARK 465 ALA B 308 REMARK 465 LEU B 309 REMARK 465 GLU B 310 REMARK 465 HIS B 311 REMARK 465 HIS B 312 REMARK 465 HIS B 313 REMARK 465 HIS B 314 REMARK 465 HIS B 315 REMARK 465 HIS B 316 REMARK 465 MET C 0 REMARK 465 ALA C 1 REMARK 465 ASN C 2 REMARK 465 LYS C 3 REMARK 465 ASP C 4 REMARK 465 GLY C 5 REMARK 465 PRO C 6 REMARK 465 VAL C 7 REMARK 465 CYS C 8 REMARK 465 MET D 200 REMARK 465 ALA D 201 REMARK 465 GLY D 202 REMARK 465 LYS D 203 REMARK 465 GLU D 204 REMARK 465 LYS D 205 REMARK 465 LEU D 206 REMARK 465 PRO D 207 REMARK 465 THR D 305 REMARK 465 ALA D 306 REMARK 465 ALA D 307 REMARK 465 ALA D 308 REMARK 465 LEU D 309 REMARK 465 GLU D 310 REMARK 465 HIS D 311 REMARK 465 HIS D 312 REMARK 465 HIS D 313 REMARK 465 HIS D 314 REMARK 465 HIS D 315 REMARK 465 HIS D 316 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 10 CG CD OE1 NE2 REMARK 470 LYS A 12 CG CD CE NZ REMARK 470 LEU A 25 CG CD1 CD2 REMARK 470 THR A 46 OG1 CG2 REMARK 470 GLU A 48 CG CD OE1 OE2 REMARK 470 LYS A 49 CG CD CE NZ REMARK 470 GLU A 50 CG CD OE1 OE2 REMARK 470 GLU A 52 CG CD OE1 OE2 REMARK 470 GLU A 159 CG CD OE1 OE2 REMARK 470 LYS B 208 CG CD CE NZ REMARK 470 LYS B 234 CG CD CE NZ REMARK 470 GLU B 278 CG CD OE1 OE2 REMARK 470 LYS C 12 CG CD CE NZ REMARK 470 LEU C 25 CG CD1 CD2 REMARK 470 GLU C 48 CG CD OE1 OE2 REMARK 470 GLU C 50 CG CD OE1 OE2 REMARK 470 GLU C 159 CG CD OE1 OE2 REMARK 470 GLN C 167 CG CD OE1 NE2 REMARK 470 LYS D 208 CG CD CE NZ REMARK 470 MET D 209 CG SD CE REMARK 470 LYS D 234 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 28 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 29 79.09 -153.19 REMARK 500 ASP A 80 70.09 53.28 REMARK 500 SER A 111 -175.56 -172.69 REMARK 500 ASP B 253 14.39 -147.16 REMARK 500 ALA B 274 57.81 -152.58 REMARK 500 SER C 111 -177.71 -173.12 REMARK 500 ALA D 274 61.32 -171.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF 'PEPTIDE INHIBITOR REMARK 800 (ACE)VDV(3PX)D-CHO' REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF 'PEPTIDE INHIBITOR REMARK 800 (ACE)VDV(3PX)D-CHO' DBREF 3RJM A 2 168 UNP P42575 CASP2_HUMAN 167 333 DBREF 3RJM B 201 305 UNP P42575 CASP2_HUMAN 348 452 DBREF 3RJM C 2 168 UNP P42575 CASP2_HUMAN 167 333 DBREF 3RJM D 201 305 UNP P42575 CASP2_HUMAN 348 452 DBREF 3RJM E 401 406 PDB 3RJM 3RJM 401 406 DBREF 3RJM F 401 406 PDB 3RJM 3RJM 401 406 SEQADV 3RJM MET A 0 UNP P42575 EXPRESSION TAG SEQADV 3RJM ALA A 1 UNP P42575 EXPRESSION TAG SEQADV 3RJM MET B 200 UNP P42575 EXPRESSION TAG SEQADV 3RJM ALA B 306 UNP P42575 EXPRESSION TAG SEQADV 3RJM ALA B 307 UNP P42575 EXPRESSION TAG SEQADV 3RJM ALA B 308 UNP P42575 EXPRESSION TAG SEQADV 3RJM LEU B 309 UNP P42575 EXPRESSION TAG SEQADV 3RJM GLU B 310 UNP P42575 EXPRESSION TAG SEQADV 3RJM HIS B 311 UNP P42575 EXPRESSION TAG SEQADV 3RJM HIS B 312 UNP P42575 EXPRESSION TAG SEQADV 3RJM HIS B 313 UNP P42575 EXPRESSION TAG SEQADV 3RJM HIS B 314 UNP P42575 EXPRESSION TAG SEQADV 3RJM HIS B 315 UNP P42575 EXPRESSION TAG SEQADV 3RJM HIS B 316 UNP P42575 EXPRESSION TAG SEQADV 3RJM MET C 0 UNP P42575 EXPRESSION TAG SEQADV 3RJM ALA C 1 UNP P42575 EXPRESSION TAG SEQADV 3RJM MET D 200 UNP P42575 EXPRESSION TAG SEQADV 3RJM ALA D 306 UNP P42575 EXPRESSION TAG SEQADV 3RJM ALA D 307 UNP P42575 EXPRESSION TAG SEQADV 3RJM ALA D 308 UNP P42575 EXPRESSION TAG SEQADV 3RJM LEU D 309 UNP P42575 EXPRESSION TAG SEQADV 3RJM GLU D 310 UNP P42575 EXPRESSION TAG SEQADV 3RJM HIS D 311 UNP P42575 EXPRESSION TAG SEQADV 3RJM HIS D 312 UNP P42575 EXPRESSION TAG SEQADV 3RJM HIS D 313 UNP P42575 EXPRESSION TAG SEQADV 3RJM HIS D 314 UNP P42575 EXPRESSION TAG SEQADV 3RJM HIS D 315 UNP P42575 EXPRESSION TAG SEQADV 3RJM HIS D 316 UNP P42575 EXPRESSION TAG SEQRES 1 A 169 MET ALA ASN LYS ASP GLY PRO VAL CYS LEU GLN VAL LYS SEQRES 2 A 169 PRO CYS THR PRO GLU PHE TYR GLN THR HIS PHE GLN LEU SEQRES 3 A 169 ALA TYR ARG LEU GLN SER ARG PRO ARG GLY LEU ALA LEU SEQRES 4 A 169 VAL LEU SER ASN VAL HIS PHE THR GLY GLU LYS GLU LEU SEQRES 5 A 169 GLU PHE ARG SER GLY GLY ASP VAL ASP HIS SER THR LEU SEQRES 6 A 169 VAL THR LEU PHE LYS LEU LEU GLY TYR ASP VAL HIS VAL SEQRES 7 A 169 LEU CYS ASP GLN THR ALA GLN GLU MET GLN GLU LYS LEU SEQRES 8 A 169 GLN ASN PHE ALA GLN LEU PRO ALA HIS ARG VAL THR ASP SEQRES 9 A 169 SER CYS ILE VAL ALA LEU LEU SER HIS GLY VAL GLU GLY SEQRES 10 A 169 ALA ILE TYR GLY VAL ASP GLY LYS LEU LEU GLN LEU GLN SEQRES 11 A 169 GLU VAL PHE GLN LEU PHE ASP ASN ALA ASN CYS PRO SER SEQRES 12 A 169 LEU GLN ASN LYS PRO LYS MET PHE PHE ILE GLN ALA CYS SEQRES 13 A 169 ARG GLY ASP GLU THR ASP ARG GLY VAL ASP GLN GLN ASP SEQRES 1 B 117 MET ALA GLY LYS GLU LYS LEU PRO LYS MET ARG LEU PRO SEQRES 2 B 117 THR ARG SER ASP MET ILE CYS GLY TYR ALA CYS LEU LYS SEQRES 3 B 117 GLY THR ALA ALA MET ARG ASN THR LYS ARG GLY SER TRP SEQRES 4 B 117 TYR ILE GLU ALA LEU ALA GLN VAL PHE SER GLU ARG ALA SEQRES 5 B 117 CYS ASP MET HIS VAL ALA ASP MET LEU VAL LYS VAL ASN SEQRES 6 B 117 ALA LEU ILE LYS ASP ARG GLU GLY TYR ALA PRO GLY THR SEQRES 7 B 117 GLU PHE HIS ARG CYS LYS GLU MET SER GLU TYR CYS SER SEQRES 8 B 117 THR LEU CYS ARG HIS LEU TYR LEU PHE PRO GLY HIS PRO SEQRES 9 B 117 PRO THR ALA ALA ALA LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 C 169 MET ALA ASN LYS ASP GLY PRO VAL CYS LEU GLN VAL LYS SEQRES 2 C 169 PRO CYS THR PRO GLU PHE TYR GLN THR HIS PHE GLN LEU SEQRES 3 C 169 ALA TYR ARG LEU GLN SER ARG PRO ARG GLY LEU ALA LEU SEQRES 4 C 169 VAL LEU SER ASN VAL HIS PHE THR GLY GLU LYS GLU LEU SEQRES 5 C 169 GLU PHE ARG SER GLY GLY ASP VAL ASP HIS SER THR LEU SEQRES 6 C 169 VAL THR LEU PHE LYS LEU LEU GLY TYR ASP VAL HIS VAL SEQRES 7 C 169 LEU CYS ASP GLN THR ALA GLN GLU MET GLN GLU LYS LEU SEQRES 8 C 169 GLN ASN PHE ALA GLN LEU PRO ALA HIS ARG VAL THR ASP SEQRES 9 C 169 SER CYS ILE VAL ALA LEU LEU SER HIS GLY VAL GLU GLY SEQRES 10 C 169 ALA ILE TYR GLY VAL ASP GLY LYS LEU LEU GLN LEU GLN SEQRES 11 C 169 GLU VAL PHE GLN LEU PHE ASP ASN ALA ASN CYS PRO SER SEQRES 12 C 169 LEU GLN ASN LYS PRO LYS MET PHE PHE ILE GLN ALA CYS SEQRES 13 C 169 ARG GLY ASP GLU THR ASP ARG GLY VAL ASP GLN GLN ASP SEQRES 1 D 117 MET ALA GLY LYS GLU LYS LEU PRO LYS MET ARG LEU PRO SEQRES 2 D 117 THR ARG SER ASP MET ILE CYS GLY TYR ALA CYS LEU LYS SEQRES 3 D 117 GLY THR ALA ALA MET ARG ASN THR LYS ARG GLY SER TRP SEQRES 4 D 117 TYR ILE GLU ALA LEU ALA GLN VAL PHE SER GLU ARG ALA SEQRES 5 D 117 CYS ASP MET HIS VAL ALA ASP MET LEU VAL LYS VAL ASN SEQRES 6 D 117 ALA LEU ILE LYS ASP ARG GLU GLY TYR ALA PRO GLY THR SEQRES 7 D 117 GLU PHE HIS ARG CYS LYS GLU MET SER GLU TYR CYS SER SEQRES 8 D 117 THR LEU CYS ARG HIS LEU TYR LEU PHE PRO GLY HIS PRO SEQRES 9 D 117 PRO THR ALA ALA ALA LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 E 6 ACE VAL ASP VAL 3PX ASJ SEQRES 1 F 6 ACE VAL ASP VAL 3PX ASJ MODRES 3RJM 3PX E 405 PRO (3S)-3-(PROPAN-2-YLOXY)-L-PROLINE MODRES 3RJM 3PX F 405 PRO (3S)-3-(PROPAN-2-YLOXY)-L-PROLINE HET ACE E 401 3 HET 3PX E 405 11 HET ASJ E 406 8 HET ACE F 401 3 HET 3PX F 405 11 HET ASJ F 406 8 HETNAM ACE ACETYL GROUP HETNAM 3PX (3S)-3-(PROPAN-2-YLOXY)-L-PROLINE HETNAM ASJ (3S)-3-AMINO-4-HYDROXYBUTANOIC ACID FORMUL 5 ACE 2(C2 H4 O) FORMUL 5 3PX 2(C8 H15 N O3) FORMUL 5 ASJ 2(C4 H9 N O3) FORMUL 7 HOH *220(H2 O) HELIX 1 1 THR A 15 PHE A 23 1 9 HELIX 2 2 GLN A 24 ALA A 26 5 3 HELIX 3 3 GLY A 56 LEU A 71 1 16 HELIX 4 4 THR A 82 GLN A 95 1 14 HELIX 5 5 LEU A 96 VAL A 101 5 6 HELIX 6 6 LEU A 128 PHE A 135 1 8 HELIX 7 7 CYS A 140 GLN A 144 5 5 HELIX 8 8 TRP B 238 ALA B 251 1 14 HELIX 9 9 HIS B 255 ARG B 270 1 16 HELIX 10 10 THR C 15 PHE C 23 1 9 HELIX 11 11 GLY C 56 LEU C 71 1 16 HELIX 12 12 THR C 82 GLN C 95 1 14 HELIX 13 13 LEU C 96 VAL C 101 5 6 HELIX 14 14 LEU C 128 PHE C 135 1 8 HELIX 15 15 CYS C 140 GLN C 144 5 5 HELIX 16 16 TRP D 238 ALA D 251 1 14 HELIX 17 17 HIS D 255 ARG D 270 1 16 SHEET 1 A12 TYR A 73 CYS A 79 0 SHEET 2 A12 GLY A 35 SER A 41 1 N ALA A 37 O HIS A 76 SHEET 3 A12 SER A 104 LEU A 110 1 O ALA A 108 N LEU A 38 SHEET 4 A12 LYS A 148 GLN A 153 1 O MET A 149 N CYS A 105 SHEET 5 A12 MET B 217 TYR B 221 1 O GLY B 220 N PHE A 150 SHEET 6 A12 GLU B 287 SER B 290 -1 O CYS B 289 N CYS B 219 SHEET 7 A12 GLU D 287 SER D 290 -1 O SER D 290 N TYR B 288 SHEET 8 A12 MET D 217 TYR D 221 -1 N TYR D 221 O GLU D 287 SHEET 9 A12 LYS C 148 GLN C 153 1 N PHE C 150 O GLY D 220 SHEET 10 A12 SER C 104 LEU C 110 1 N CYS C 105 O MET C 149 SHEET 11 A12 GLY C 35 SER C 41 1 N LEU C 38 O ALA C 108 SHEET 12 A12 TYR C 73 CYS C 79 1 O HIS C 76 N ALA C 37 SHEET 1 B 3 GLY A 113 VAL A 114 0 SHEET 2 B 3 ALA A 117 TYR A 119 -1 O ALA A 117 N VAL A 114 SHEET 3 B 3 LEU A 125 GLN A 127 -1 O LEU A 126 N ILE A 118 SHEET 1 C 2 VAL A 164 ASP A 165 0 SHEET 2 C 2 ARG D 210 LEU D 211 -1 O LEU D 211 N VAL A 164 SHEET 1 D 3 GLY B 236 SER B 237 0 SHEET 2 D 3 MET B 230 ASN B 232 -1 N ASN B 232 O GLY B 236 SHEET 3 D 3 ASP E 403 3PX E 405 -1 O VAL E 404 N ARG B 231 SHEET 1 E 3 GLY C 113 VAL C 114 0 SHEET 2 E 3 ALA C 117 TYR C 119 -1 O ALA C 117 N VAL C 114 SHEET 3 E 3 LEU C 125 GLN C 127 -1 O LEU C 126 N ILE C 118 SHEET 1 F 3 GLY D 236 SER D 237 0 SHEET 2 F 3 MET D 230 ASN D 232 -1 N ASN D 232 O GLY D 236 SHEET 3 F 3 ASP F 403 3PX F 405 -1 O VAL F 404 N ARG D 231 SSBOND 1 CYS B 289 CYS D 289 1555 1555 2.11 LINK SG CYS A 155 C ASJ E 406 1555 1555 1.74 LINK SG CYS C 155 C ASJ F 406 1555 1555 1.78 LINK C ACE E 401 N VAL E 402 1555 1555 1.34 LINK C 3PX E 405 N ASJ E 406 1555 1555 1.33 LINK C ACE F 401 N VAL F 402 1555 1555 1.34 LINK C 3PX F 405 N ASJ F 406 1555 1555 1.33 CISPEP 1 ARG A 32 PRO A 33 0 1.35 CISPEP 2 HIS B 302 PRO B 303 0 6.11 CISPEP 3 ARG C 32 PRO C 33 0 -3.03 CISPEP 4 HIS D 302 PRO D 303 0 -7.62 SITE 1 AC1 16 ARG A 54 HIS A 112 GLN A 153 CYS A 155 SITE 2 AC1 16 ASP A 158 THR A 160 ALA B 228 ALA B 229 SITE 3 AC1 16 MET B 230 ARG B 231 ASN B 232 THR B 233 SITE 4 AC1 16 TRP B 238 GLY B 272 TYR B 273 HOH E 220 SITE 1 AC2 17 ARG C 54 HIS C 112 GLN C 153 CYS C 155 SITE 2 AC2 17 ASP C 158 THR C 160 ALA D 228 ALA D 229 SITE 3 AC2 17 MET D 230 ARG D 231 ASN D 232 THR D 233 SITE 4 AC2 17 TRP D 238 GLY D 272 TYR D 273 PHE D 279 SITE 5 AC2 17 HOH F 216 CRYST1 63.770 97.380 97.980 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015681 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010269 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010206 0.00000